The Epstein-Barr Virus Regulome in Lymphoblastoid Cells

Cell Host and Microbe

Volumn 22, Issue 4, 2017, Pages 561-573.e4

  Jiang, Sizun ^a,b   Zhou, Hufeng ^a,b   Liang, Jun ^a,b   Gerdt, Catherine ^a   Wang, Chong ^a,b   Ke, Liangru ^a,c   Schmidt, Stefanie C S ^a,b   Narita, Yohei ^a,b   Ma, Yijie ^a,b   Wang, Shuangqi ^d   Colson, Tyler ^a   Gewurz, Benjamin ^a   Li, Guoliang ^d   Kieff, Elliott ^a,b   Zhao, Bo ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

CDKN2A B; ChIA PET; EBV regulome; EBV super enhancers; Epstein Barr virus; MYC

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; INTERFERON REGULATORY FACTOR 4; MYC PROTEIN; PROTEIN MCL 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH2; CDKN2A PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2C; EBF1 PROTEIN, HUMAN; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EPSTEIN BARR VIRUS ANTIGEN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4; MATRIX PROTEIN; MCL1 PROTEIN, HUMAN; MYC PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL TRANSFORMATION; CHROMATIN; CONTROLLED STUDY; ENHANCER REGION; EPSTEIN BARR VIRUS; ESSENTIAL GENE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SENESCENCE; TUMOR SUPPRESSOR GENE; B LYMPHOCYTE; CELL LINE; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PRIMARY CELL CULTURE; VIROLOGY;

B-LYMPHOCYTES; CELL LINE; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P18; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTORS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-MYC; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

EID: 85032514322     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.09.001     Document Type: Article

References (74)

1. Adelman, K., Lis, J.T., Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13 (2012), 720–731.
2. Alfieri, C., Birkenbach, M., Kieff, E., Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181 (1991), 595–608.
3. Arvey, A., Tempera, I., Tsai, K., Chen, H.S., Tikhmyanova, N., Klichinsky, M., Leslie, C., Lieberman, P.M., An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 12 (2012), 233–245.
4. Bailey, S.D., Zhang, X., Desai, K., Aid, M., Corradin, O., Cowper-Sal Lari, R., Akhtar-Zaidi, B., Scacheri, P.C., Haibe-Kains, B., Lupien, M., ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nat. Commun., 2, 2015, 6186.
5. Banerjee, S., Lu, J., Cai, Q., Saha, A., Jha, H.C., Dzeng, R.K., Robertson, E.S., The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8. PLoS Pathog., 9, 2013, e1003314.
6. Bazot, Q., Deschamps, T., Tafforeau, L., Siouda, M., Leblanc, P., Harth-Hertle, M.L., Rabourdin-Combe, C., Lotteau, V., Kempkes, B., Tommasino, M., et al. Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1. Nucleic Acids Res. 42 (2014), 9700–9716.
7. Brinkman, E.K., Chen, T., Amendola, M., van Steensel, B., Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res., 42, 2014, e168.
8. Cahir-McFarland, E.D., Davidson, D.M., Schauer, S.L., Duong, J., Kieff, E., NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 97 (2000), 6055–6060.
9. Calderwood, M.A., Holthaus, A.M., Johannsen, E., The Epstein-Barr virus LF2 protein inhibits viral replication. J. Virol. 82 (2008), 8509–8519.
10. Cohen, J.I., Fauci, A.S., Varmus, H., Nabel, G.J., Epstein-Barr virus: an important vaccine target for cancer prevention. Sci. Transl. Med., 3, 2011, 107fs107.
11. Dekker, J., Rippe, K., Dekker, M., Kleckner, N., Capturing chromosome conformation. Science 295 (2002), 1306–1311.
12. Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B.L., Xavier, R.J., Root, D.E., Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 32 (2014), 1262–1267.
13. Elgendy, M., Sheridan, C., Brumatti, G., Martin, S.J., Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol. Cell 42 (2011), 23–35.
14. Epstein, M.A., Achong, B.G., Barr, Y.M., Virus particles in cultured lymphoblasts from Burkitt's Lymphoma. Lancet 1 (1964), 702–703.
15. Faumont, N., Durand-Panteix, S., Schlee, M., Gromminger, S., Schuhmacher, M., Holzel, M., Laux, G., Mailhammer, R., Rosenwald, A., Staudt, L.M., et al. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells. J. Virol. 83 (2009), 5014–5027.
16. Finke, J., Rowe, M., Kallin, B., Ernberg, I., Rosen, A., Dillner, J., Klein, G., Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61 (1987), 3870–3878.
17. Greenfeld, H., Takasaki, K., Walsh, M.J., Ersing, I., Bernhardt, K., Ma, Y., Fu, B., Ashbaugh, C.W., Cabo, J., Mollo, S.B., et al. TRAF1 coordinates polyubiquitin signaling to enhance Epstein-Barr virus LMP1-mediated growth and survival pathway activation. PLoS Pathog., 11, 2015, e1004890.
18. Grossman, S.R., Johannsen, E., Tong, X., Yalamanchili, R., Kieff, E., The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91 (1994), 7568–7572.
19. Harada, S., Kieff, E., Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J. Virol. 71 (1997), 6611–6618.
20. Harth-Hertle, M.L., Scholz, B.A., Erhard, F., Glaser, L.V., Dölken, L., Zimmer, R., Kempkes, B., Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog., 9, 2013, e1003638.
21. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., Glass, C.K., Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38 (2010), 576–589.
22. Henkel, T., Ling, P.D., Hayward, S.D., Peterson, M.G., Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265 (1994), 92–95.
23. Hickabottom, M., Parker, G.A., Freemont, P., Crook, T., Allday, M.J., Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J. Biol. Chem. 277 (2002), 47197–47204.
24. Howley, P.M., Gordon Wilson lecture: infectious disease causes of cancer: opportunities for prevention and treatment. Trans. Am. Clin. Climatol. Assoc. 126 (2015), 117–132.
25. Huang, W., Sherman, B.T., Stephens, R., Baseler, M.W., Lane, H.C., Lempicki, R.A., DAVID gene ID conversion tool. Bioinformation 2 (2008), 428–430.
26. Jiang, S., Willox, B., Zhou, H., Holthaus, A.M., Wang, A., Shi, T.T., Maruo, S., Kharchenko, P.V., Johannsen, E.C., Kieff, E., et al. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc. Natl. Acad. Sci. USA 111 (2014), 421–426.
27. Johannsen, E., Luftig, M., Chase, M.R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., Kieff, E., Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 101 (2004), 16286–16291.
28. Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G.W., Kempkes, B., The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J. Virol. 73 (1999), 4481–4484.
29. Kalchschmidt, J.S., Gillman, A.C., Paschos, K., Bazot, Q., Kempkes, B., Allday, M.J., EBNA3C directs recruitment of RBPJ (CBF1) to chromatin during the process of gene repression in EBV infected B cells. PLoS Pathog., 12, 2016, e1005383.
30. Kempkes, B., Spitkovsky, D., Jansen-Durr, P., Ellwart, J.W., Kremmer, E., Delecluse, H.J., Rottenberger, C., Bornkamm, G.W., Hammerschmidt, W., B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 14 (1995), 88–96.
31. Kheradmand Kia, S., Solaimani Kartalaei, P., Farahbakhshian, E., Pourfarzad, F., von Lindern, M., Verrijzer, C.P., EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. Epigenetics Chromatin, 2, 2009, 16.
32. Langmead, B., Trapnell, C., Pop, M., Salzberg, S.L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, 2009, R25.
33. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics 25 (2009), 2078–2079.
34. Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K.M., Kieff, E., Zhao, B., Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc. Natl. Acad. Sci. USA 113 (2016), 14121–14126.
35. Lieberman-Aiden, E., van Berkum, N.L., Williams, L., Imakaev, M., Ragoczy, T., Telling, A., Amit, I., Lajoie, B.R., Sabo, P.J., Dorschner, M.O., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326 (2009), 289–293.
36. Ling, P.D., Rawlins, D.R., Hayward, S.D., The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 90 (1993), 9237–9241.
37. Ling, P.D., Peng, R.S., Nakajima, A., Yu, J.H., Tan, J., Moses, S.M., Yang, W.H., Zhao, B., Kieff, E., Bloch, K.D., et al. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J. 24 (2005), 3565–3575.
38. Longnecker, R., Kieff, E., Cohen, J.I., Epstein-Barr Virus, Vol. 2. Eighth Edition, 2013, Lippincott Williams & Wilkins, a Wolters Kluwer Business.
39. Ma, Y., Walsh, M.J., Bernhardt, K., Ashbaugh, C.W., Trudeau, S.J., Ashbaugh, I.Y., Jiang, S., Jiang, C., Zhao, B., Root, D.E., et al. CRISPR/Cas9 screens reveal Epstein-Barr virus-transformed B cell host dependency factors. Cell Host Microbe 21 (2017), 580–591.e7.
40. Maier, H., Ostraat, R., Gao, H., Fields, S., Shinton, S.A., Medina, K.L., Ikawa, T., Murre, C., Singh, H., Hardy, R.R., et al. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5 (2004), 1069–1077.
41. Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Kieff, E., Epstein-Barr virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J. Virol. 77 (2003), 10437–10447.
42. Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B., Kieff, E., Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. J. Virol. 79 (2005), 10171–10179.
43. Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D., Takada, K., Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 103 (2006), 19500–19505.
44. Maruo, S., Wu, Y., Ito, T., Kanda, T., Kieff, E.D., Takada, K., Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc. Natl. Acad. Sci. USA 106 (2009), 4419–4424.
45. Maruo, S., Zhao, B., Johannsen, E., Kieff, E., Zou, J., Takada, K., Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc. Natl. Acad. Sci. USA 108 (2011), 1919–1924.
46. Ochiai, K., Maienschein-Cline, M., Simonetti, G., Chen, J., Rosenthal, R., Brink, R., Chong, A.S., Klein, U., Dinner, A.R., Singh, H., et al. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 38 (2013), 918–929.
47. Ohashi, M., Holthaus, A.M., Calderwood, M.A., Lai, C.Y., Krastins, B., Sarracino, D., Johannsen, E., The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. PLoS Pathog., 11, 2015, e1004822.
48. Ong, C.T., Corces, V.G., Enhancer function: new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 12 (2011), 283–293.
49. Paschos, K., Parker, G.A., Watanatanasup, E., White, R.E., Allday, M.J., BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res. 40 (2012), 7233–7246.
50. Patnaik, A., Rosen, L.S., Tolaney, S.M., Tolcher, A.W., Goldman, J.W., Gandhi, L., Papadopoulos, K.P., Beeram, M., Rasco, D.W., Hilton, J.F., et al. Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, non-small cell lung cancer, and other solid tumors. Cancer Discov. 6 (2016), 740–753.
51. Perciavalle, R.M., Stewart, D.P., Koss, B., Lynch, J., Milasta, S., Bathina, M., Temirov, J., Cleland, M.M., Pelletier, S., Schuetz, J.D., et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat. Cell Biol. 14 (2012), 575–583.
52. Phanstiel, D.H., Boyle, A.P., Heidari, N., Snyder, M.P., Mango: a bias-correcting ChIA-PET analysis pipeline. Bioinformatics 31 (2015), 3092–3098.
53. Portal, D., Zhao, B., Calderwood, M.A., Sommermann, T., Johannsen, E., Kieff, E., EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc. Natl. Acad. Sci. USA 108 (2011), 7808–7813.
54. Portal, D., Zhou, H., Zhao, B., Kharchenko, P.V., Lowry, E., Wong, L., Quackenbush, J., Holloway, D., Jiang, S., Lu, Y., et al. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc. Natl. Acad. Sci. USA 110 (2013), 18537–18542.
55. Quinlan, A.R., Hall, I.M., BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26 (2010), 841–842.
56. Robertson, E.S., Lin, J., Kieff, E., The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J. Virol. 70 (1996), 3068–3074.
57. Ryan, J.L., Fan, H., Glaser, S.L., Schichman, S.A., Raab-Traub, N., Gulley, M.L., Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J. Mol. Diagn. 6 (2004), 378–385.
58. Schmidt, S.C., Jiang, S., Zhou, H., Willox, B., Holthaus, A.M., Kharchenko, P.V., Johannsen, E.C., Kieff, E., Zhao, B., Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proc. Natl. Acad. Sci. USA 112 (2015), 554–559.
59. Shaffer, A.L., Lin, K.I., Kuo, T.C., Yu, X., Hurt, E.M., Rosenwald, A., Giltnane, J.M., Yang, L., Zhao, H., Calame, K., et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17 (2002), 51–62.
60. Shen, L., Shao, N., Liu, X., Nestler, E., ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics, 15, 2014, 284.
61. Sherr, C.J., Beach, D., Shapiro, G.I., Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov. 6 (2016), 353–367.
62. Sinclair, A.J., Palmero, I., Peters, G., Farrell, P.J., EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13 (1994), 3321–3328.
63. Skalska, L., White, R.E., Franz, M., Ruhmann, M., Allday, M.J., Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog., 6, 2010, e1000951.
64. Skalska, L., White, R.E., Parker, G.A., Sinclair, A.J., Paschos, K., Allday, M.J., Induction of p16(INK4A) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog., 9, 2013, e1003187.
65. Tang, Z., Luo, O.J., Li, X., Zheng, M., Zhu, J.J., Szalaj, P., Trzaskoma, P., Magalska, A., Wlodarczyk, J., Ruszczycki, B., et al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell 163 (2015), 1611–1627.
66. Wang, A., Welch, R., Zhao, B., Ta, T., Keles, S., Johannsen, E., Epstein-Barr virus nuclear antigen 3 (EBNA3) proteins regulate EBNA2 binding to distinct RBPJ genomic sites. J. Virol. 90 (2015), 2906–2919.
67. Wang, S., Rowe, M., Lundgren, E., Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res. 56 (1996), 4610–4613.
68. Whyte, Warren A., Orlando, David A., Hnisz, D., Abraham, Brian J., Lin, Charles Y., Kagey, Michael H., Rahl, Peter B., Lee, Tong I., Young, Richard A., Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153 (2013), 307–319.
69. Wood, C.D., Veenstra, H., Khasnis, S., Gunnell, A., Webb, H.M., Shannon-Lowe, C., Andrews, S., Osborne, C.S., West, M.J., MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Elife, 5, 2016, e18270.
70. Zhao, B., Barrera, L.A., Ersing, I., Willox, B., Schmidt, S.C., Greenfeld, H., Zhou, H., Mollo, S.B., Shi, T.T., Takasaki, K., et al. The NF-kappaB genomic landscape in lymphoblastoid B cells. Cell Rep. 8 (2014), 1595–1606.
71. Zhao, B., Maruo, S., Cooper, A., R Chase, M., Johannsen, E., Kieff, E., Cahir-McFarland, E., RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103 (2006), 1900–1905.
72. Zhao, B., Zou, J., Wang, H., Johannsen, E., Peng, C.W., Quackenbush, J., Mar, J.C., Morton, C.C., Freedman, M.L., Blacklow, S.C., et al. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc. Natl. Acad. Sci. USA 108 (2011), 14902–14907.
73. Zhou, H., Jin, J., Zhang, H., Yi, B., Wozniak, M., Wong, L., IntPath – an integrated pathway gene relationship database for model organisms and important pathogens. BMC Syst. Biol., 6(Suppl 2), 2012, S2.
74. Zhou, H., Schmidt, S.C., Jiang, S., Willox, B., Bernhardt, K., Liang, J., Johannsen, E.C., Kharchenko, P., Gewurz, B.E., Kieff, E., et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe 17 (2015), 205–216.